ClinicalTrials.gg
RecruitingNCT07069179CTM-RRUpdated Mar 12, 2026

Feasibility of Choose to Move Replacement Ready

An interventional study of Choose to Move Replacement Ready in Osteoarthritis, Osteoarthritis (OA) of the Knee and Osteoarthritis, Hip, sponsored by University of British Columbia. Recruiting at 1 site in Canada. Open to participants aged 50 Years and older. Per ClinicalTrials.gov, last updated 2026-03-12.

Primary conditionOsteoarthritis, HipRegistry: OsteoarthritisReclassifiedWhy we changed it
Registry
Osteoarthritis — the first condition term the registry derived for this study.
ClinicalTrials.gg
Osteoarthritis, Hip
Why
  1. The study's listed conditions name Osteoarthritis, Hip, a narrower term within Osteoarthritis.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by University of British Columbia · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Started Jul 2025; still recruiting 1 year 3 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Not applicable
Ages
50 Years and older
Sex
All
01

Study summary

Choose to Move (CTM) is a 3-month, choice-based health-promoting program for low active older adults being scaled-up across British Columbia (BC), Canada. Recently, the investigators adapted CTM for the >14000 people in BC who are on surgical waitlists for total knee replacement or total hip replacement (TKR/THR) for osteoarthritis (OA). The primary goal of this observational study is to learn if the adapted program, Choose to Move Replacement Ready (CTM-RR), is feasible to deliver to people with hip and/or knee osteoarthritis who are on surgical waitlists for TKR/THR.

Participants who enrol in CTM-RR will answer online survey questions about the program and about their physical activity, mobility, pain, function, quality of life, willingness to undergo surgery, overall perception of their joint condition, psychosocial health, self-efficacy, social isolation, loneliness, and sedentary time. CTM-RR activity coaches will also answer online survey questions about the program. CTM-RR participants, activity coaches, and referral partners will also participate in interviews about the program.

Read the detailed description

Choose to Move (CTM) an effective 3-month, choice-based health-promoting program for low active older adults being scaled-up in phases across British Columbia (BC), Canada. Choose to Move Replacement Ready (CTM-RR) is an adapted version of the program tailored to support individuals with hip and/or knee osteoarthritis on surgical waitlists for TKR/THR, with the overall goal of enhancing key health outcomes. Trained activity coaches hired by the Active Aging Society will deliver CTM-RR to individuals on surgical waitlists for TKR/THR. The investigators will then evaluate implementation of CTM-RR, and the impact of CTM-RR on participants' physical and social health.

The primary objective of this trial is to:

  1. Assess implementation outcomes (participant recruitment, retention, dose delivered/received, fidelity) of the adapted CTM model against predetermined feasibility targets.

    The secondary objectives are to:

  2. Describe implementation determinants (acceptability, feasibility, appropriateness) and outcomes (reach, adaptations, perceived participant responsiveness, adoption) of the adapted CTM model.
  3. Evaluate the preliminary estimates of effectiveness of CTM-RR. Specifically, whether CTM-RR increases participants' pre-operative moderate-to-vigorous physical activity, light physical activity, mobility, psychosocial health, and self-efficacy to manage their condition; improves their perception of their joint condition, function, and quality of life; and decreases pain, social isolation, loneliness, and sedentary time
  4. Assess whether participant-level health benefits, if any, are maintained 3 months after participants complete the CTM-RR program.

In partnership with the Active Aging Society, the investigators aim to deliver 6 CTM-RR online programs over 9-months to approximately 60 participants total across BC. There is no cost to participate in the CTM-RR program, and individuals may participate in CTM-RR regardless of whether they choose to be evaluated as part of this trial.

The investigators will conduct a feasibility trial using a hybrid implementation-effectiveness type 2 trial design. Data will be collected at 0 (baseline), 3 (post-intervention), and 6 (long-term follow-up) months to assess implementation and impact of CTM-RR, and maintenance of any program-related benefits. The investigators will also collect physical activity logs from program participants (weekly, during program participation).

02

Conditions studied

  • Osteoarthritis
  • Osteoarthritis (OA) of the Knee
  • Osteoarthritis, Hip
  • Total Knee Arthroplasty; Total Hip Arthroplasty
  • Mobility Limitation
  • Social Isolation or Loneliness
  • Pain
  • Implementation Science
  • Physical Inactivity
  • Sedentary Behaviors

Keywords

  • Osteoarthritis
  • Implementation science
  • Social isolation
  • Physical activity
  • Mobility
  • Loneliness
  • Pain
  • Joint replacement
  • Feasibility
  • Acceptability
  • Fidelity
03

In context

Osteoarthritis, Hip Reclassified

641 studies on the registry are indexed under Osteoarthritis, Hip; 120 are open to participants now.

This study's planned enrollment of 60 is below the median of 90 across 457 interventional studies indexed under Osteoarthritis, Hip.

Browse Osteoarthritis, Hip studies →

Lead sponsor

University of British Columbia is the lead sponsor of 1,339 studies on the registry; 259 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 1 (17%) have results posted.

Compared within Osteoarthritis, Hip, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Osteoarthritis. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
50 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Activity coach hired by the Active Aging Society (activity coaches must speak English to participate in the evaluation);
  2. English-speaking older adults (aged >=50 years) who participate in CTM-RR will be invited to participate in the evaluation
  3. Referral partner (People who work in a healthcare setting who refer patients into the program)

Exclusion criteria

Exclusion Criteria:

  1. non-English speaking activity coach
  2. non-English speaking referral partner
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Choose to Move Replacement Ready

    CTM-RR is a 3-month program for individuals with hip and/or knee osteoarthritis on surgical waitlists for total hip or total knee replacement that includes three required components: 1) a 30-min one-on-one virtual consultation (via Zoom) where activity coaches support participants to set goals and develop a PA action plan; 2) 8 virtual group meetings (via Zoom, 90-min each) facilitated by activity coaches, with small groups of participants (10/program) who provide peer support. Each meeting includes: i) two, 15-min movement breaks where participants perform structured hip and knee exercises delivered by the coach and ii) education and discussion on relevant topics (e.g. goal setting, PA, what to expect from surgery); 3) Home-based hip and knee exercises to complete independently, 2x/week. Optional components of CTM-RR include 4) a bi-weekly newsletter distributed by the AAS and 5) peer support check-ins outside of group meetings.

    Behavioral: Choose to Move Replacement Ready

Interventions

  • BehavioralChoose to Move Replacement Ready

    As described under study arm description.

06

What researchers measure

Primary outcomes

  1. Implementation Outcome: Recruitment

    Obtained from program records. Proportion of people who attend the program information session, are eligible, and enrol in the program. Feasibility Target: Enrol 50% of people attending the program information session who are eligible to participate to the program.

    Time frame: baseline

  2. Implementation Outcome: Retention

    Obtained from evaluation records. Proportion of participants who consent to the evaluation who complete each follow-up assessment. Feasibility target: A minimum of 80% of participants who consented to the evaluation (and are in the pre-operative period) completing each follow-up assessment.

    Time frame: baseline, 3, 6 months

  3. Implementation Outcome: Dose delivered

    Obtained from post-program survey. Proportion of required intervention components (group meetings and one-on-one consultations) delivered by activity coaches. Feasibility target: Activity coaches delivering 90% of required intervention components (group meetings and one-on-one consultations).

    Time frame: 3 months

  4. Implementation Outcome: Dose received

    Obtained from post-program survey. Proportion of participants who consent to the evaluation, attending required intervention components (group meetings and one-on-one consultation) Feasibility target: Participants who consent to the evaluation attending 6 out of 9 (\>60%) of required intervention components (group meetings and one-on-one consultation)

    Time frame: 3 months

  5. Implementation Outcome: Fidelity (Proportion of participants who adhered to prescribed exercise)

    Obtained from post-program survey. Measures adherence to prescribed frequency, intensity, duration, and type of exercises performed. 80% of participants adhered to all of the following criteria: * on average, frequency= two sessions per week or greater * on average, intensity= 7 out of 10 rating of perceived exertion or greater * on average, duration= 20 minutes or greater * on average, exercises were completed as prescribed without omission or substitution of prescribed exercises

    Time frame: 3 months

  6. Adverse events: Number of adverse events

    Obtained from post-program survey. Number of adverse events related to Choose to Move: Replacement Ready that required medical treatment and/or lasted two or more days.

    Time frame: 3 months

Secondary outcomes

  1. Change in physical activity

    Single-item physical activity questionnaire. Output measure is self-reported number of days engaging in ≥30 minutes of moderate-to-vigorous physical activity in the past week (range 0-7). Higher scores reflect a better outcome (i.e. increased physical activity)

    Time frame: baseline, 3, 6 months

  2. Change in walking time

    International Physical Activity Questionnaire (IPAQ-SF): assesses self-reported weekly minutes of walking (minutes per week)

    Time frame: baseline, 3, 6 months

  3. Change in sedentary time

    International Physical Activity Questionnaire (IPAQ-SF): assesses self-reported weekly minutes of sedentary time

    Time frame: baseline, 3, 6 months

  4. Change in bone and muscle strengthening activity

    Single-item muscle strengthening activity survey. Number of days in past week doing activities that increase bone and muscle strength

    Time frame: baseline, 3, 6 months

  5. Change in balance activity

    Single-item activity survey. Number of days in past week doing activities that improve balance.

    Time frame: baseline, 3, 6 months

  6. Change in capacity for mobility

    Short-Form-36 health survey (SF-36) Physical Functioning Scale: two items assess self-reported ability to walk ¼ mile and 1 flight of stairs.

    Time frame: baseline, 3, 6 months

  7. Change in social isolation

    Social Isolation Questionnaire: score (0-15) reflects the degree of social interaction and support. Higher scores indicate a greater level of social interaction and support.

    Time frame: baseline, 3, 6 months

  8. Change in loneliness

    The 3-item U.S. Health and Retirement Study Participant Lifestyle Questionnaire reflects experiences of loneliness. Each item is scored on a scale of 1-3. The output variable is the summed score of the 3 items (range 3-9); Higher scores indicate greater perceived loneliness.

    Time frame: baseline, 3, 6 months

  9. Change in ability to participate in daily activities

    The four-item PROMIS- Ability to Participate in Social Roles and Activities Scale- short form 4a will be used to assess perceived ability to perform one's usual social roles and activities. Each item is scored on a scale of 1-5. The output variable is the summed raw score of all 4-items (range 4-20) converted into a T-score (27.5-64.2) ; higher scores indicate greater ability to engage in social roles and activities.

    Time frame: baseline, 3, 6 months

  10. Change in Hip disability and Osteoarthritis Outcome 12-item Score

    The 12-item Hip Disability and Osteoarthritis Outcome Score (HOOS-12) assesses patients' hip condition (pain, function, quality of life). Each item is scored on a scale of 0-10. The output variable is the average score of the 12-items (range 0-100); higher scores indicate worse hip problems.

    Time frame: baseline, 3, 6 months

  11. Change in Knee disability and Osteoarthritis Outcome 12-item Score

    The 12-item Knee Disability and Osteoarthritis Outcome Score (KOOS-12) assesses patients' knee condition (pain, function, quality of life). Each item is scored on a scale of 0-10. The output variable is the average score of the 12-items (range 0-100); higher scores indicate worse knee problems.

    Time frame: baseline, 3, 6 months

  12. Change in patient global assessment of target joint

    Single-item measure using a numerical rating scale: score (0-10) assesses the overall condition of the affected hip or knee joint. Higher scores indicate worse condition (severe symptoms).

    Time frame: baseline, 3, 6 months

  13. Change in arthritis-specific self-efficacy

    The 8-item questionnaire assesses how certain an individual is that they can manage various aspects of their arthritis. Each item is scored on a scale of 1-10. The output variable is the average score of all 8-items (range 8-80); higher scores indicate more self-efficacy.

    Time frame: baseline, 3, 6 months

  14. Change in pain intensity

    Pain Numerical Rating Scale (NRS): score (0-10) assesses pain intensity on average during the past week. Higher scores indicate worse pain intensity.

    Time frame: baseline, 3, 6 months

  15. Change in willingness to undergo surgery

    One item will assess participants' willingness to undergo hip or knee replacement surgery. The question asks: "What is your current willingness to undergo a \[total hip replacement surgery or total knee replacement surgery\]?" The response options are: definitely unwilling, probably unwilling, unsure, probably willing or definitely willing. Definitely unwilling, probably unwilling, unsure= No, and probably willing or definitely willing=Yes. The output variable is self-reported willingness to undergo surgery (yes/no).

    Time frame: baseline, 3, 6 months

  16. Change in anxiety

    The Generalized Anxiety Disorder 7-item scale (GAD-7) will be used to assess the presence of anxiety. Each item is scored on a scale of 0-3. The output variable is the summed total of all scores (range 0-21); higher scores indicate greater levels of anxiety.

    Time frame: baseline, 3, 6 months

  17. Change in kinesiophobia

    The 11-item Tampa Scale for Kinesiophobia (TSK-11) assesses fear of movement in individuals with chronic pain. Each item is scored on a scale of 1-4. The output variable is the total summed score of all 11-items (range 11-44); higher scores indicate greater fear of movement.

    Time frame: baseline, 3, 6 months

Other outcomes

  1. Acceptability - CTM-RR program

    Acceptability of Intervention Measure (AIM). Activity coaches' perception that CTM-RR is agreeable or satisfactory will be assessed by survey (4 items each on a 1-5 Likert scale with 1 being completely disagree and 5 being completely agree).

    Time frame: 3 months

  2. Appropriateness - CTM-RR program

    Intervention Appropriateness Measure (IAM). Extent to which CTM-RR fits the needs of the target population will be assessed by survey (4 items each on a 1-5 Likert scale with 1 being completely disagree and 5 being completely agree)

    Time frame: 3 months

  3. Feasibility - CTM-RR program

    Feasibility of Intervention Measure (FIM). Activity coaches' perception that CTM-RR is feasible to deliver will be assessed by survey (4 items each on a 1-5 Likert scale with 1 being completely disagree and 5 being completely agree).

    Time frame: 3 months

  4. Reach

    Number of individuals participating in CTM-RR programs will be obtained from program records.

    Time frame: 3 months

  5. Adoption

    Obtained from program records. Number of referral partners who refer participants to the program.

    Time frame: baseline

  6. Satisfaction with CTM-RR (survey)

    Satisfaction with CTM-RR will be assessed via participant (older adults) survey (designed in house). Higher scores (1-5 Likert scale) indicate higher participant satisfaction with the intervention.

    Time frame: 3 months

  7. Perceived participant responsiveness (survey)

    Perceived participant responsiveness will be assessed via participant (older adults) survey ( short answer responses; developed in house). Older adults will indicate which optional intervention components they engaged in (peer check-in, e-mail newsletter, hip and knee exercises; yes/no response options)

    Time frame: 3 months

  8. Adaptation (survey)

    Planned or purposeful changes to the delivery of CTM-RR by activity coaches will be assessed by survey (short answer responses; developed in house). Coaches will indicate if they made any adaptations to the program (yes/no) and to provide details of any adaptations such as why it needed to occur.

    Time frame: 3 months

  9. Perceived participant responsiveness (survey)

    Perceived participant responsiveness will be assessed via participant (activity coach) survey (developed in house). Activity coaches will indicate whether participants were interactive, enthusiastic, interested, and engaged during group meetings.

    Time frame: 3 months

  10. Adaptation (interview)

    Planned or purposeful changes to the delivery of CTM-RR by activity coaches will be assessed by interview.

    Time frame: 3 months

  11. Experience with training and program delivery (interview)

    Activity coaches overall experience with program training and delivery, will be assessed by interview

    Time frame: 3 months

  12. Perceived participant responsiveness (interview)

    Activity coaches perceptions of participant responsiveness will be assessed by interview.

    Time frame: 3 months

  13. Adaptations (interview)

    Older adults' perceptions of potential adaptations to improve the program will be assessed by interview

    Time frame: 3 months

  14. Perceived participant responsiveness (interview)

    Older adults' responsiveness during the program will be assessed by interview.

    Time frame: 3 months

  15. Acceptability- CTM-RR program (interview)

    Older adults' perceptions that the program is acceptable or satisfactory will be assessed by interview.

    Time frame: 3 months

  16. Feasibility- CTM-RR program (interview)

    Older adults' perceptions of the program's feasibility will be assessed by interview.

    Time frame: 3 months

  17. Appropriateness- CTM-RR program (interview)

    Older adults' perceptions of the program's appropriateness will be assessed by interview.

    Time frame: 3 months

  18. Feasibility - CTM-RR referral process (interview)

    Referral partners' perception that the CTM-RR referral process can be used successfully within the organization will be assessed by interview.

    Time frame: 3 months

  19. Acceptability - CTM-RR referral process (interview)

    Referral partners' perception that the CTM-RR referral process is acceptable or satisfactory will be assessed by interview.

    Time frame: 3 months

  20. Appropriateness - CTM-RR referral process (interview)

    Referral partners' perception regarding the extent to which the CTM-RR referral process fits with the mission, priorities, and values of the organization will be assessed by interview.

    Time frame: 3 months

  21. Physical activity goal setting

    At the start of the program, older adult participants complete an Action Plan with support from their activity coach. They record a physical activity goal that is specific, measurable, attainable, relevant, and time-based (SMART). Action Plans will be collected and information from the Action Plans will be reported descriptively.

    Time frame: baseline

  22. Self-reported physical activity participation

    Older adult participants will record the type and duration of physical activities they engaged in over the past 7 days on a weekly basis during CTM-RR. Data will be reported descriptively.

    Time frame: Weekly (from baseline to 3 months)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Peer MA, Lane J. The Knee Injury and Osteoarthritis Outcome Score (KOOS): a review of its psychometric properties in people undergoing total knee arthroplasty. J Orthop Sports Phys Ther. 2013 Jan;43(1):20-8. doi: 10.2519/jospt.2013.4057. Epub 2012 Dec 7. PubMed 23221356 ↗
  • Nilsdotter AK, Lohmander LS, Klassbo M, Roos EM. Hip disability and osteoarthritis outcome score (HOOS)--validity and responsiveness in total hip replacement. BMC Musculoskelet Disord. 2003 May 30;4:10. doi: 10.1186/1471-2474-4-10. Epub 2003 May 30. PubMed 12777182 ↗
  • Weiner BJ, Lewis CC, Stanick C, Powell BJ, Dorsey CN, Clary AS, Boynton MH, Halko H. Psychometric assessment of three newly developed implementation outcome measures. Implement Sci. 2017 Aug 29;12(1):108. doi: 10.1186/s13012-017-0635-3. PubMed 28851459 ↗
  • Hawker GA, Bohm E, Dunbar MJ, Faris P, Jones CA, Noseworthy T, Ravi B, Woodhouse LJ, Marshall DA; BEST-Knee Study Team. Patient appropriateness for total knee arthroplasty and predicted probability of a good outcome. RMD Open. 2023 Apr;9(2):e002808. doi: 10.1136/rmdopen-2022-002808. PubMed 37068914 ↗
  • Alghadir AH, Anwer S, Iqbal A, Iqbal ZA. Test-retest reliability, validity, and minimum detectable change of visual analog, numerical rating, and verbal rating scales for measurement of osteoarthritic knee pain. J Pain Res. 2018 Apr 26;11:851-856. doi: 10.2147/JPR.S158847. eCollection 2018. PubMed 29731662 ↗
  • Jensen MP, Karoly P, Braver S. The measurement of clinical pain intensity: a comparison of six methods. Pain. 1986 Oct;27(1):117-126. doi: 10.1016/0304-3959(86)90228-9. PubMed 3785962 ↗
  • Roos EM, Roos HP, Lohmander LS, Ekdahl C, Beynnon BD. Knee Injury and Osteoarthritis Outcome Score (KOOS)--development of a self-administered outcome measure. J Orthop Sports Phys Ther. 1998 Aug;28(2):88-96. doi: 10.2519/jospt.1998.28.2.88. PubMed 9699158 ↗
  • Klassbo M, Larsson E, Mannevik E. Hip disability and osteoarthritis outcome score. An extension of the Western Ontario and McMaster Universities Osteoarthritis Index. Scand J Rheumatol. 2003;32(1):46-51. doi: 10.1080/03009740310000409. PubMed 12635946 ↗
  • Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res. 2002 Feb;52(2):69-77. doi: 10.1016/s0022-3999(01)00296-3. PubMed 11832252 ↗
  • Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003 Aug;35(8):1381-95. doi: 10.1249/01.MSS.0000078924.61453.FB. PubMed 12900694 ↗
  • Durlak JA, DuPre EP. Implementation matters: a review of research on the influence of implementation on program outcomes and the factors affecting implementation. Am J Community Psychol. 2008 Jun;41(3-4):327-50. doi: 10.1007/s10464-008-9165-0. PubMed 18322790 ↗
  • McKay H, Naylor PJ, Lau E, Gray SM, Wolfenden L, Milat A, Bauman A, Race D, Nettlefold L, Sims-Gould J. Implementation and scale-up of physical activity and behavioural nutrition interventions: an evaluation roadmap. Int J Behav Nutr Phys Act. 2019 Nov 7;16(1):102. doi: 10.1186/s12966-019-0868-4. PubMed 31699095 ↗
  • Proctor E, Silmere H, Raghavan R, Hovmand P, Aarons G, Bunger A, Griffey R, Hensley M. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Adm Policy Ment Health. 2011 Mar;38(2):65-76. doi: 10.1007/s10488-010-0319-7. PubMed 20957426 ↗
  • Bauer GR, Braimoh J, Scheim AI, Dharma C. Transgender-inclusive measures of sex/gender for population surveys: Mixed-methods evaluation and recommendations. PLoS One. 2017 May 25;12(5):e0178043. doi: 10.1371/journal.pone.0178043. eCollection 2017. PubMed 28542498 ↗
  • Veroff JB. The dynamics of help-seeking in men and women: a national survey study. Psychiatry. 1981 Aug;44(3):189-200. PubMed 7267859 ↗
  • Simonsick EM, Newman AB, Visser M, Goodpaster B, Kritchevsky SB, Rubin S, Nevitt MC, Harris TB; Health, Aging and Body Composition Study. Mobility limitation in self-described well-functioning older adults: importance of endurance walk testing. J Gerontol A Biol Sci Med Sci. 2008 Aug;63(8):841-7. doi: 10.1093/gerona/63.8.841. PubMed 18772472 ↗
  • Macdonald HM, Nettlefold L, Bauman A, Sims-Gould J, McKay HA. Pragmatic Evaluation of Older Adults' Physical Activity in Scale-Up Studies: Is the Single-Item Measure a Reasonable Option? J Aging Phys Act. 2022 Feb 1;30(1):25-32. doi: 10.1123/japa.2020-0412. Epub 2021 Aug 4. PubMed 34348228 ↗
  • Hughes ME, Waite LJ, Hawkley LC, Cacioppo JT. A Short Scale for Measuring Loneliness in Large Surveys: Results From Two Population-Based Studies. Res Aging. 2004;26(6):655-672. doi: 10.1177/0164027504268574. PubMed 18504506 ↗
  • Milton K, Bull FC, Bauman A. Reliability and validity testing of a single-item physical activity measure. Br J Sports Med. 2011 Mar;45(3):203-8. doi: 10.1136/bjsm.2009.068395. Epub 2010 May 19. PubMed 20484314 ↗
  • Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C. Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care. 2012 Mar;50(3):217-26. doi: 10.1097/MLR.0b013e3182408812. PubMed 22310560 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07069179
Collaborators
Active Aging Society, Specialist Services Committee (Doctors of BC)
Responsible party
Heather McKay (Professor, University of British Columbia) — Principal investigator
First posted
Jul 16, 2025
Start date
Jul 14, 2025
Primary completion
Mar 2028 (estimated)
Completion
Mar 2028 (estimated)
Last update
Mar 12, 2026

Study contacts

Douglas L Race, MSc
Contact
douglas.race@ubc.ca
604-875-4111' ext. 21787
Christa Hoy, MSc
Contact
christa.hoy@ubc.ca
604-675-2581
Heather A. McKay, PhD
principal investigator · University of British Columbia
Laura Churchill, PT, PhD
principal investigator · University of British Columbia
Joanie Sims Gould, MSW, PhD
principal investigator · University of British Columbia

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion